Need professional-grade analysis? Visit stockanalysis.com
$1.21B
13.10
8,356
6.82%
Price Chart
Risk-Adjusted Performance
Terveystalo Oy (TTALO) Price Performance
Terveystalo Oy (TTALO) trades on Nasdaq Helsinki in EUR. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at EUR9.16, down 2.76% from the previous close.
Over the past year, TTALO has traded between a low of EUR9.02 and a high of EUR12.24. The stock has lost 21.2% over this period. It is currently 25.2% below its 52-week high.
Terveystalo Oy has a market capitalization of $1.21B, with a price-to-earnings ratio of 13.10 and a dividend yield of 6.82%.
About Terveystalo Oy
Terveystalo Oyj provides occupational healthcare services in Finland, Sweden, and Estonia. It operates through three segments: Healthcare Services, Portfolio Businesses, and Sweden. The company offers general practice and specialist medical care, diagnostic, outpatient surgery, dental, and other adjacent services; healthcare outsourcing and staffing services; child welfare services; and oral health, social, ER, well-being, and primary healthcare and specialty care services, as well as imaging and laboratory tests. It also provides remote and digital, diagnostic and screening, therapy and rehabilitation, and occupational health; leasing of personnel, partnership solutions, and assessment of the need for care; and organizational management consulting and addiction prevention services. The company serves private individuals and families, corporate and consumer, insurance companies, and public sector customers. Terveystalo Oyj was founded in 2001 and is headquartered in Helsinki, Finland.
Company Info
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- Nasdaq Helsinki
- Currency
- EUR
- Country
- Finland
Financial Metrics
- Revenue (TTM)
- $1.28B
- EBITDA
- $191.80M
- Profit Margin
- 7.24%
- EPS (TTM)
- 0.73
- Book Value
- 4.61
Technical Indicators
- 52 Week High
- €12.28
- 52 Week Low
- €8.95
- 50 Day MA
- €9.68
- 200 Day MA
- €10.11
- Beta
- 0.42
Valuation
- Trailing P/E
- 13.10
- Forward P/E
- N/A
- Price/Sales
- 0.95
- Price/Book
- 2.04
- Enterprise Value
- $1.69B